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Summary: A simple Spectrophotometric assay for serum guanase based on the oxidation of 2,2'-azino-di(3-
ethylbenzthiazpline-6-sulphate) (ABTS) using xanthine oxidase, uricase and peroxidase is described and
statistically examined through its application to normal and pathological sera. The method is very sensitive,
precise (CV below 8.13%) and linear up to 152.5 U/l. Comparison with the methods of Hue & Free ((1965)
Clin. Chem. 11, 708-715), and Giusti ((1974) In: Methods of Enzymatic Analysis, Bergmeyer, H. U., ed.,
p. 1086), and Ito et al. ((1981) Clin. Chim. Acta 115, 135-144) gave a good correlation (r ^ 0.969). The
reference values for the ABTS-method are 2.93 to 23.92 U/l (x = 13.57 U/l, CV = 22.43%). The mean
values of guanase äctivities determined in sera of patients with different liver diseases (x = 30.29 U/l), or
chronic alcoholics (x = 35.41 U/l) were significantly higher than normal. The patients with chronic diseases
had significantly lower activity (x = 7.22 U/l, t = 9.25, p < 0.001).
Evaluation der spektrophotometrischen Bestimmung von Guanase mit 2,2'-Azino-di(3-ethylbenzthiazol-6-sulfo-
nat) als Chromogen
Zusammenfassung: Eine einfache spektrophotometrische Bestimmung für Guanase im Serum auf Grundlage
der Oxidation von 2,2'-Azino-di(3-ethylbenzthiazol-6-sulfonat) (ABTS) mit Xanthinoxydase, Uricase und
Peroxidase wird beschriebeil und hinsichtlich ihrer Anwendung auf normale und pathologische Seren unter-
sucht. Die Methode ist sehr empfindlich, genau (VK unter 8,13%) und linear bis 152,5 U/l. Ein Vergleich
mit den Methoden von Hue & Free ((1965) Clin. Chem. 11, 708-715) sowie Giusti ((1974) In: Methods of
Enzymatic Analysis, Bergmeyer, H. U., ed., p. 1086) und Ito et al. ((1981) Clin. Chim. Acta 115, 135-144)
ergaben eine gute Korrelation (r ^ 0,969). Die Referenzwerte für die ABTS-Methode sind 2,93 bis 23,92 U/l
(x = 13,57 U/l, VK =3 22,43%). Die Mittelwerte der katalytischen Konzentration von Guanase im Serum
von Patienten mit verschiedenen Lebererkrankungen (x = 30,29 U/l), oder chronischen Alkoholikern (x =
35,41 U/l) waren signifikant höher als normal. Die Patienten mit chronischen Erkrankungen zeigten eine
signifikant niedrigere katalytische Konzentration (x = 7,22 U/l, t = 9,25, p < 0,001).
n o uc on Many methods have been used for guanase assay.
Guanine deaminase (guanase, guanine aminohydro- They are based either on measurements of the de-
lase, EC 3.5.4.3) plays an important role in the catab- crease in absorbance at 245 nm (4), or measurement
olism of purines. Guanase catalyses the hydrolytic of the ammonia formed by guanase action (5 — 7). If
deamiiiation of guanine into xanthine and ammonia. xanthine is oxidized by xanthine oxidase (xanthine:
The enzyme is present in many animal and human oxygen oxidoreductase, EC 1.2.3.2), guanase catalytic
tissues (l, 2). in humans, high äctivities have been activity can be measured via uric acid (8, 9) or H2O2
found in liver, kidney and brain, and little or no formed in thisreaction (10, 11); O2 consumption also
activity in other organs (2, 3). can be measured (12). A more sensitive radiochemical
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assay has also been described, based on the measure-
ment of the radioactive uric acid produced upon
incubation with radioactive guanine and excess xan-
thine oxidase (13, 14).
In the present guanase assay we used the chromogen,
2,2/-azino-di(3-ethylbenzthiazoline-6-sulphonate)
(ABTS), which is stoichiometrically oxidized in the
following System of coupled reactions:
Guanine -l· H2O Guanase * Xanthine + NH3
XanthineoxidXanthine
ri2<J H" ^2
Uric acid + H2O uricase ^ Allantoin -l· H2O2
+ O2 * -l· CO2
H202 + ABTSred Peroxidase » ABTSOX + 2H2O
The absorbance of oxidized ABTS recorded at 410
nm is directly proportional to guanase activity in the
sample.
The method was statistically evaluated. Reference
values were determined, and the method was applied
to different pathological sera.
Reagent solution
Based on the determination of optimal conditions, a reagent
with the following composition was made: 4.55 mmol ABTS
and 2500 U peroxidase in 1000 ml of 66.7 mmol/1 phosphate
buffer, pH 7.0. This solution is stable more than tw.o months.
Spectrophotometric assay of guanase
The new Spectrophotometric method for guanase is based oh
oxidation of chromogen ABTS through the System of coupled
reactions catalysed by xanthine oxidase, uricase and peroxidase.
To optimize this assay, the conditions characterizing this mul-
tiple reaction System were studied. Km for guanine s Substrate
is 7.54 μιηοΙ/1. The maximal guanase activity measured at 37 °C
was obtained with 95.23 μιηοΐ/ΐ guanine, 25.23 U/l xanthine
oxidase, 76.19 U/l uricase, 819.6 U/l peroxidase and 1.49
mmol/1 of ABTS in 66.7 mmol/1 phosphate buffer, pH 7.0. The
uricase reaction increased the sensitivity of the method, yielding
another molecule of H^O^ Positive interference by the endoge^
nous uric acid is avoided by measuring the test absorbance
against a blank containing uricase.
Procedure
Substrate-buffer solution (1.0 ml) and 50 μΐ of guanase sample
are mixed well and incubated 10 minutes at 37 °C in a centrifuge
tube. Add 1.0 ml of reagent solution, vortex and immediately
add l .0 ml of HC1O4 (4 mol/1). Vortex again and centrifuge for
5 minutes at 3000 min"1. The absorbance of the clear super-
natant is read at 410 nm against a blank (containing 1.0 ml
phosphate buffer, 5 μΐ uricase, 50 μΐ sample, l .0 'ml reagent
solution and 1.0 ml HC1O4) prepared in the same way s the
test. The final reaction product is stable for 360 minutes.
Materials and Methods
Chemicals
The diammonium salt of 2,2'-azino-di(3-ethylbenzthiazoline-6-
sulphonate) cryst., guanase from rabbit liver, Suspension in
ammonium sulphate solution, 3.3 mol/1, pH ca, 6, spec. activity
60 U/g and horseradish peroxidase, spec. activity 250 U/mg
were purchased from Boehringer-Mannheim, FR . Guanine,
xanthine oxidase (bovine milk), crystalline Suspension in 3.3
mol/1 ammonium sulphate, spec. activity 2.65 kU/1 were from
Calbiochem-Behring Corp. Uricase from porcine liver, ca. 10
U/mg in 50% glycerol pH 9.3 (1.6 g/l) was obtained from
Serva, Heidelberg, FRG. Sodium azide puriss was obtained
from Koch-Light Laboratories, LTD, England. All other chemi-
cals of analytical grade were from Merck-Darmstadt, FRG. All
Solutions were prepared with doubly distilled water.
Biological materials
The investigations were carried on different human (normal
and pathological) sera, serum pools and control sera Kontrollo-
gen L, Lu and LP obtained from Behringwerke, Marburg,




This solution contains 100 μηιοί guanine, 26.5 U xanthine oxi-
dase, 76.19 U uricase and 20 mmol sodium azide in 1000 ml of
66.7 mmol/1 phosphate buffer, pH 7.0. It is stable 30 minutes
at room temperature and should be prepared before use. Other-
wise xanthine oxidase and uricase must be pipetted separately.
Calculation
The guanase catalytic activity was calculated s A41onm x 119.5
on the basis of ABTSOX molar lineic absorbance which is 2550
m2/mol (15).
Statistics
Statistical parameters such s the mean value (x), Standard
deviation (SD), coefficients of Variation (CV) and Standard
error (s*) were calculated with Standard Statistical methods.
Regression analysis: the parameters a (intercept with abscissa),
sa (Standard error of a), ta (Student's t-test for sa), b (slope of
regression line), sb (Standard error of b), and tb (Studenfs t-test
for sb) were calculated using the least-squares method (16). Our
method was compared with the methods of Hue & Free (4),
Giusti (17), Wolthers et al. (7) and Ito et al. (18). The principle
of the Hue & Free method (4) is measurement of the decrease
in absorbance at 245 nm due to guanine. For determination of
guanase in the Giusti method (17), xanthine oxidase is used s
the indicator enzyme. The reaction is followed by spectfophoto-
metric measurements of resulting uric acid at 290 nm. The
method of Wolthers et al. (7) is based on the enzymatic eonver-
sion of ammonia by glutamate dehydrpgenase in the presence
of 2-oxoglutarate and NADH. The guanase assay by Ito et al.
(18) is based on direct colorimetric determination of released
ammonia using the phenol-nitroprusside reagent.
The ranges of reference values were calculated with a non-
parametric method (16). *
Apparatus
All measurements were performed with a Unicam SP 8000A
spectrophotometer equipped with a Haake FS thermostat and
Weyfringe ADCP-2 printer. v ?
J. .Clin. Chem. Clin. Biochem. / Vol. 24,1986 / No. 6
Majkic-Singh et al.: Guanase assay with 2,2/-azino-di(3-ethylbenzthiazoline-6-sulphonate) (ABTS) 389
Results
Linearity and sensitivity
The linearity of the ABTS-method was examined with
Standard Solutions of guanase prepared by dilution
of commercially available guanase (spec. activity ca.
60 U/g) with 66.7 mmol/1 phosphate buffer, pH 7.0
in the ränge 0 to 152 U/l. Each solution was analysed
in duplicate. By applying the correlation analysis to
the results, the regression equation, yx = 0,034 +
120.033x (r = 0.999, sy,x = 0.865, sa = 0,212, ta =
0.160) was calculated, which shows that the method
is linear up to 149 U/l. Good linearity in this ränge
was confirmed by addition of different amounts of
guanase to a serum pool. Regression analysis applied
to the values obtained showed that the Lambert—
Beer law was valid up to 152.5 U/l (yx = 0.028 +
O.OOSlx, sx,y = 0.993, sa = 0.045, ta = 0.623, p >
0.6). The lowest catalytic activity of guanase that
could still be assayed with good precision (CV =
5.4%) was 0.11 U/l (fig. 1).



























The precision of the ABTS-method was examined
with Solutions of commercially obtained guanase,
serum pools containing low, normal and pathological
activity of guanase, and also with control sera Kon-
trologen L, LU and LP. All determination were re-
peated 12 times and calculated mean values, Standard






















































Fig. 1. Linearity of the ABTS-method: yx = 0.034 +
120.033 x, r = 0.999, SyX = 0.865, sa = 0.212, ta =
0.160, p > 0.05.
Recovery
We investigated anälytical recovery by adding guan-
ase Solutions to the seruin pool to give total catalytic
activities of guanase up to 152.45 U/l. The results
shown in table l are averages of duplicate assays and
indicate the anälytical recovery of guanase added to
serum was quantitative (yx = 5.850 + 0.999x, r =
0.001, sx,y = 8.493, sa = 7.968, ta == 0.734, sb =
0.076, tb'= 0.551).
Inter-method comparison
The accuracy of the ABTS-method was evaluated by
comparison of the results obtained in normal and
pathological serum samples with four other methods.
Pathological serum samples were obtained from
patients with acute and chronic pancreatitis, liver
cirrhosis, hepatoma, chronic pyelonephritis and
chronic glomerulonephritis. The correlations are pre-
sented in table 3 and figures 2 and 3. Comparison
with the methods of Hue & Free (4), Giusti (17) and
Ito et al. (18) gave good correlation. The ABTS-
method gave values that were 4 and 2 U/l higher than
those obtained by the methods of Hue & Free (4)
and Ito et al. (18), respectively. In comparison to the
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Tab. 3. Regression analysis of serum guanase catalytic activity concentrations by the ABTS-method (y) vs. results by four other
methods (x).
Method (ref.)
Hue & Free (4)
G/utfi(17)



























































Guanase (Hue and Free method) TU/U
Fig. 2. Correlation of "results obtained by the ABTS-method
(y) and Hue and Free's method (x) in 47 different human
sera:
yx = 4.214 + 1.052 x, r = 0.977, sy 0.975.
Giusti method (17), the ABTS-method gave higher
values up to an activity of 58.9 U/l, and lower values
above this value. No correlation was found with
method of Wolthers et al. (7).
Reference values
Estimation of guanase catalytic activity by the ABTS-
method was performed on the sera of 86 healthy
females and 173 males between 20 and 60 years of
age. The mean values obtained were 13.18 /l (SD
= 3.017 U/l, CV = 22.9%) and 13.95 U/l (SD =
3.11 U/l, CV = 22.3%), respectively. By Studenfs t-
test (t = 1.893, p > 0.05) the statistically significant
difference was not proved and all results are observed
together. Using a nonparametric method (16) the
reference values for sefuin guanase activity in the
r nge 2.93 to 23.92 U/l (x = 13.57 U/l, SD = 3.04
U/l, CV = 22.4%) were calculated (see fig. 4).
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Fig. 3. Correlation of results obtained by the ABTS-method Fig. 4. Histogram of reference values for serum guanase deter-
W and Ito s method (x) m 43 different human sera: mined by the ABTS-method in the sera of 259 healthy
yx = 1.831 + 1.003 x, r = 0.969, sy,x = 1.114. persons aged between 20 and;57.
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Pathological guanase activity
By the new ABTS-method guanase activities were
determined in sera obtained from 40 patients with
different liver diseases, 33 patients with chronic kid-
ney diseases, 40 drug-dependent patients and 46 alco-

























Patients Alco- Drug Patients
with holics dependent with chronic
liver patients kidney
diseases diseases
Fig. 5. Guanase activities determined in sera of patients with
liver diseases, alcoholics, drug-dependent patients and
patients with chronic kidney diseases.
Discussion
The present work describes a simple assay of guanase
activity via H2O2 which is formed äs a product of
cpupled reactions catalysed by xanthine oxidase and
uricase. Xanthine formed in the hydrolytic guanase
reaction is oxidized by xanthine oxidase to uric acid
and H2O2. However, urie acid competes with ABTS
for H2Ö2 in the presence öf peroxidase^(19, 20). For
this rfeason, an auxillary reaction was introduced to
,decompose uric acid by uricase, and the indicator
reagent was added after completipn of the incubation.
In addition, the uricase reaction increased the sensi-
tivity of the method, yielding another molecule of
H2O2. Also, this procedure enables the oxidätion of
uric acid present in serum sämples. Positive interfer-
ence by endogenous uric acid in serum is avoided by
measuring the test absorbance against a sample blank
containing uricase. If catalase (hydrogen-peroxide:
hydrogen-peroxide oxidoreductase, EC 1.11.1.6) is
present in the sample it can decompose the H2O2
formed, causing a decrease in the ABTSOX absorbance
which corresponds to guanase activity. This effect
was avoided by addition of 9.52 mmol/1 sodium azide.
The investigation presented here showed that the
ABTS-method is sensitive, linear up to 152 U/l and
precise (CV below 8.13%). The accuracy of the
method was investigated through recovery studies
and by comparison with other known methods. The
analytical recovery was quantitive in the ränge of
linearity of method. The results obtained with the
ABTS-method in different serum sämples were com-
pared with those obtained with four other methods
based on different principles (4, 7, 17, 18). The best
agreement was obtained with Ito's method (17). The
ABTS-method did not correlate with Wolthers*
method (7) (r = 0,494).
As our method gives higher values than others, this
method was more sensitive in the ränge of reference
values. Normal catalytic activities of guanase deter-
mined by the ABTS-method in the sera of 259 healthy
persons were 3 to 7 times higher than determined by
other methods (8 — 12). The reference interval for the
ABTS-method is 2.93 to 23.92 U/l. Caraway (5) and
Hue & Free (4) reported it to be 0-3 U/l, Ellis et al.
(6) up to 2.5 U/l, Giusti (17) 0-7 U/l, Wolthers et al.
(7) 0.1-0.9 U/l, Ito et al. (18) 0.4-2.0 U/l, while
Hishikawa & Fukumoto (10) established a normal
ränge from 0 to l .02 U/l.
Due to the high activities in liver and kidney, and
the absence (or low level) in sera, determination of
guanase activity might provide diagnostic Informa-
tion about kidney and liver lesions (3, 21). Increased
serum activities in hepatic disorders have already
been demonstrated in a number of publications (3,
22, 23). Kuzmits et al. (24) stated that guanase is
an extremely sensitive marker for liver cell damage.
Furthermore, it was reported that guanase determina-
tions are of diagnostic value in patients with renal
diseases (25, 26), since reduced activities were found
in patients with chronic kidney diseases (25).
To evaluate the reliability of results obtained by the
ABTS-method, this method was applied to sera of
patients with different liver and kidney disorders. The
mean guanase activities determined by the ABTS-
method in sera of patients with different liver diseases
(x = 30.20 U/l, SD = 10.73 U/l), chronic alcoholics
(x == 33.29 U/l, SD = 17.12 U/l), and drug-depen-
dent patients (x = 35.41 U/l, SD = 13.05 U/l) were
significantly higher then in normal persons. Patients
with chronic kidney diseases had significantly lower
activity (x = 7.22 U/l, SD = 6.97, t = 9.25, p <
0.001).
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Finally, we conclude that the newly developed
method for guanase determination, which uses ABTS
äs a chromogen, is specific, more sensitive than some
other methods, and has good reproducibility. To
evaluate the ABTS-method äs a routine method for
the differential diagnosis of liver and kidney diseases,
serum guanase activities should be determined in
various hepatic and kidney diseases and correlated
with other enzymes used for the diagnosis of liver
and kidney dysfunction.
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